The detection of differentiation-inducing chemicals by using green fluorescent protein expression in genetically engineered teratocarcinoma cells

Alternatives to Laboratory Animals

Volumn 33, Issue 2, 2005, Pages 91-103

  Adler, Sarah ^a   Paparella, Martin ^a   Pellizzer, Cristian ^a   Hartung, Thomas ^a   Bremer, Susanne ^a  

^a JOINT RESEARCH CENTRE   (Italy)

Author keywords

Alternative tests; Differentiation; Dimethyl sulphoxide; Embryonal teratocarcinoma cells; Green fluorescent protein; mTert; Retinoids; Telomerase; Teratogenicity

Indexed keywords

ALCOHOL; ALITRETINOIN; DIMETHYL SULFOXIDE; GREEN FLUORESCENT PROTEIN; ISOTRETINOIN; RETINOIC ACID; RETINOID; RNA DIRECTED DNA POLYMERASE; SACCHARIN; TELOMERASE; TERATOGENIC AGENT;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; CYTOTOXICITY TEST; EMBRYOTOXICITY; GENE; GENE CONSTRUCT; GENE EXPRESSION; GENE SEQUENCE; GENETIC ENGINEERING; GENETIC MANIPULATION; GENETIC TRANSFECTION; HEART MUSCLE; MTERT GENE; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; SKELETAL MUSCLE; TERATOCARCINOMA; TERATOGENICITY;

ANIMALIA; MURINAE;

EID: 18844406449     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290503300204     Document Type: Article

References (51)

1. Anon. (2001). White Paper on a Strategy for a Future Chemicals Policy: Commission of the European Communities. Website http//europa.eu.int/comm/ enviroment/chemicals/whitepaper.htm (Accessed 1.7.03).
2. McBurney, M.W. & Rogers, B.J. (1982). Isolation of male embryonal carcinoma cells and their chromosome replication patterns. Developmental Biology 89, 503-508.
3. van der Heyden, M.A. & Defize, L.H. (2003). Twenty one years of P19 cells: what an embryonal carcinoma cell line taught us about cardiomyocyte differentiation. Cardiovascular Research 58, 292-302.
4. Knowles, B.B., Aden, D.P. & Solter, D. (1978). Monoclonal antibody detecting a stage-specific embryonic antigen (SSEA-1) on preimplantation mouse embryos and teratocarcinoma cells. Current Topics in Microbiology and Immunology 81, 51-53.
5. Solter, D. & Knowles, B.B. (1978). Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proceedings of the National Academy of Sciences USA 75, 5565-5569.
6. Stewart, C.L., Gadi, I. & Bhatt, H. (1994). Stem cells from primordial germ cells can reenter the germ line. Developmental Biology 161, 626-628.
7. Jones-Villeneuve, E.M., McBurney, M.W., Rogers, K.A. & Kalnins, V.I. (1982). Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. Journal of Cell Biology 94, 253-262.
8. McBurney, M.W., Jones-Villeneuve, E.M., Edwards, M.K. & Anderson, P.J. (1982). Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature, London 299, 165-167.
9. Seeley, M.R. & Faustman, E.M. (1998). Evaluation of P19 cells for studying mechanisms of developmental toxicity: application to four direct-acting alkylating agents. Toxicology 127, 49-58.
10. Wright, W.E., Piatyszek, M.A., Rainey, W.E., Byrd, W. & Shay, J.W. (1996). Telomerase activity in human germline and embryonic tissues and cells. Developmental Genetics 18, 173-179.
11. Sharma, H.W., Sokoloski, J.A., Perez, J.R., Maltese, J.Y., Sartorelli, A.C., Stein, C.A., Nichols, G., Khaled, Z., Telang, N.T. & Narayanan, R. (1995). Differentiation of immortal cells inhibits telomerase activity. Proceedings of the National Academy of Sciences USA 92, 12,343-12,346.
12. Albanell, J., Han, W., Mellado, B., Gunawardane, R., Scher, H.I., Dmitrovsky, E. & Moore, M.A. (1996). Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. Cancer Research 56, 1503-1508.
13. Holt, S.E., Wright, W.E. & Shay, J.W. (1996). Regulation of telomerase activity in immortal cell lines. Molecular and Cellular Biology 16, 2932-2939.
14. Armstrong, L., Lako, M., Lincoln, J., Cairns, P.M. & Hole, N. (2000). mTert expression correlates with telomerase activity during the differentiation of murine embryonic stem cells. Mechanisms of Development 97, 109-116.
15. Kamm, J.J. (1982). Toxicology, carcinogenicity, and teratogenicity of some orally administered retinoids. Journal of the American Academy of Dermatology 6, 652-659.
16. Kamm, J.J., Ashenfelter, K.O. & Ehmann, C.W. (1984). Preclinical and clinical toxicology of selected retinoids. Retinoids 2, 287-326.
17. Soprano, D.R. & Soprano, K.J. (1995). Retinoids as teratogens. Annual Review of Nutrition 15, 111-132.
18. Kochhar, D.M., Jiang, H., Penner, J.D. & Heyman, R.A. (1995). Placental transfer and developmental effects of 9-cis retinoic acid in mice. Teratology 51, 257-265.
19. Herrmann, K. (1995). Teratogenic effects of retinoic acid and related substances on the early development of the zebrafish (Brachydanio rerio) as assessed by a novel test system. Toxicology in Vitro 9, 267-283.
20. Crettaz, M., Baron, A., Siegenthaler, G. & Hunziker, W. (1990). Ligand specificities of recombinant retinoic acid receptors RAR alpha and RAR beta. Biochemical Journal 272, 391-397.
21. Matsushima, Y., Kawachi, E., Tanaka, H., Kagechika, H., Hashimoto, Y. & Shudo, K. (1992). Differentiation-inducing activity of retinoic acid isomers and their oxidized analogs on human promyelocytic leukemia HL-60 cells. Biochemical and Biophysical Research Communications 189, 1136-1142.
22. Allenby, G., Bocquel, M.T., Saunders, M., Kazmer, S., Speck, J., Rosenberger, M., Lovey, A., Kastner, P., Grippo, J.F., Chambon, P. & Levin, A.A. (1993). Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proceedings of the National Academy of Sciences USA 90, 30-34.
23. Tzimas, G., Burgin, H., Collins, M.D., Hummler, H. & Nau, H. (1994). The high sensitivity of the rabbit to the teratogenic effects of 13-cis-retinoic acid (isotretinoin) is a consequence of prolonged exposure of the embryo to 13-cis-retinoic acid and 13-cis-4-oxo-retinoic acid, and not of isomerization to all-trans-retinoic acid. Archives of Toxicology 68, 119-128.
24. Creech, K.J., Lofberg, B., Chahoud, I., Bochert, G. & Nau, H. (1989). Teratogenicity and placental transfer of all-trans-, 13-cis-, 4-oxo-all-trans-, and 4-oxo-13-cis-retinoic acid after administration of a low oral dose during organogenesis in mice. Toxicology and Applied Pharmacology 100, 162-176.
25. Creech, K.J., Eckhoff, C., Kochhar, D.M., Bochert, G., Chahoud, I. & Nau, H. (1991). Isotretinoin (13-cis-retinoic acid) metabolism, cis-trans isomerization, glucuronidation, and transfer to the mouse embryo: consequences for teratogenicity. Teratogenesis, Carcinogenesis, and Mutagenesis 11, 21-30.
26. + channels. Journal of Cellular Physiology 132, 387-400.
27. Wang, L. (1990). Correlation between protein kinase C and differentiation of HL-60 cells induced by DMSO. Zhongguo Yi.Xue.Ke.Xue.Yuan Xue.Bao 12, 96-100.
28. Chakravarthy, B.R., Tremblay, R., Macdonald, P., Krsmanovic, V., Whitfield, J.F. & Durkin, J.P. (1992). The activation of inactive membrane-associated protein kinase C is associated with DMSO-induced erythroleukemia cell differentiation. Biochimica et Biophysica Acta 1136, 83-90.
29. Morley, P. & Whitfield, J.F. (1993). The differentiation inducer, dimethyl sulfoxide, transiently increases the intracellular calcium ion concentration in various cell types. Journal of Cellular Physiology 156, 219-225.
30. Cocco, L., Capitani, S., Barnabei, O., Gilmour, R.S., Rhee, S.G. & Manzoli, F.A. (1999). Inositides in the nucleus: further developments on phospholipase C beta 1 signalling during erythroid differentiation and IGF-I induced mitogenesis. Advances in Enzyme Regulation. 39, 287-297.
31. Bremer, S., van Dooren, M. & Paparella, M. (1999). Establishment of an embryotoxicity assay with green fluorescence protein-expressing embryonic cell-derived cardiomyocytes. ATLA 27, 471-484.
32. Bremer, S., Worth, A.P., Paparella, M., Bigot, K., Kolossov, E., Fleischmann, B.K., Hescheler, J. & Balls, M. (2001). Establishment of an in vitro reporter gene assay for developmental cardiac toxicity. Toxicology in Vitro 15, 215-223.
33. Paparella, M., Kolossov, E., Fleischmann, B.K., Hescheler, J. & Bremer, S. (2002). The use of quantitative image analysis in the assessment of in vitro embryotoxicity endpoints based on a novel embryonic stem cell clone with endoderm-related GFP expression. Toxicology in Vitro 16, 589-597.
34. Spielmann, H., Pohl, I., Doering, B., Liebsch, M. & Moldenhauer, F. (1997). The embryonic stem cell test, an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. In Vitro Toxicolology 10, 119-127.
35. Scholz, G., Pohl, I., Genschow, E., Klemm, M. & Spielmann, H. (1999). Embryotoxicity screening using embryonic stem cells in vitro: correlation to in vivo teratogenicity. Cells, Tissues, Organs 165, 203-211.
36. Anon. (2000). Scientific Frontiers in Developmental Toxicology and Risk Assessment, 354pp. Washington, DC, USA: National Academy Press.
37. Bremer, S. & Hartung, T. (2004). The use of embryonic stem cells for regulatory developmental toxicity testing in vitro: the current status of test development. Current Pharmaceutical Design 10, 2733-2747.
38. Kolossov, E., Fleischmann, B.K., Liu, Q., Bloch, W., Viatchenko- Karpinski, S., Manzke, O., Ji, G.J., Bohlen, H., Addicks, K. & Hescheler, J. (1998). Functional characteristics of ES cell-derived cardiac precursor cells identified by tissue-specific expression of the green fluorescent protein. Journal of Cell Biology 143, 2045-2056.
39. Rudnicki, M.A. & McBurney, M.W. (1987). Cell culture methods and induction of differentiation of embryonal carcinoma cell lines. Cell culture methods and induction of differentiation of embryonal carcinoma cells. In Teratocarcinomas and Embryonic Stem Cells (ed. E.J. Robertson), pp. 19-49. Oxford, UK: IRL Press.
40. Wobus, A.M., Wallukat, G. & Hescheler, J. (1991). Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation 48, 173-182.
41. Muramatsu, T. (1988). Developmentally regulated expression of cell surface carbohydrates during mouse embryogenesis. Journal of Cellular Biochemistry 36, 1-14.
42. Edwards, M.K. & McBurney, M.W. (1983). The concentration of retinoic acid determines the differentiated cell types formed by a teratocarcinoma cell line. Developmental Biology 98, 187-191.
43. Rohwedel, J., Guan, K. & Wobus, A.M. (1999). Induction of cellular differentiation by retinoic acid in vitro. Cells, Tissues, Organs 165, 190-202.
44. Tzimas, G., Sass, J.O., Wittfoht, W., Elmazar, M.M., Ehlers, K. & Nau, H. (1994). Identification of 9,13-dicis-retinoic acid as a major plasma metabolite of 9-cis-retinoic acid and limited transfer of 9-cis-retinoic acid and 9,13-dicis-retinoic acid to the mouse and rat embryos. Drug Metabolism and Disposition 22, 928-936.
45. Kornfehl, J., Temmel, A., Formanek, M. & Knerer, B. (1999). Effects of ethanol treatment of proliferation and differentiation in a head and neck squamous cell carcinoma cell line. Alcoholism, Clinical and Experimental Research 23, 1102-1107.
46. Garriga, J., Adanero, E., Fernandez-Sola, J., Urbano-Marquez, A. & Cusso, R. (2000). Ethanol inhibits skeletal muscle cell proliferation and delays its differentiation in cell culture. Alcohol and Alcoholism 35, 236-241.
47. Laschinski, G., Vogel, R. & Spielmann, H. (1991). Cytotoxicity test using blastocyst-derived euploid embryonal stem cells: a new approach to in vitro teratogenesis screening. Reproductive Toxicology 5, 57-64.
48. Brown, N.A. (2002). Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. ATLA 30, 177-198.
49. Genschow, E., Spielmann, H., Scholz, G., Seiler, A., Brown, N., Piersma, A., Brady, M., Clemann, N., Huuskonen, H., Paillard, F., Bremer, S. & Becker, K. (2002). The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. ATLA 30, 151-176.
50. Anon. (1987). Teratology Society position paper: recommendations for vitamin A use during pregnancy. Teratology 35, 269-275.
51. Hendrickx, A.G. (1998). Teratogenicity of retinoids in rodents, primates and humans. Journal of Toxicological Sciences 23, 272-272.